SCM
AURA icon

Sterling Capital Management’s Aura Biosciences AURA Stock Holding History

Sterling Capital Management’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.46K Sell
205
-916
-82% -$6.55K ﹤0.01% 3061
2026
Q1 		$7.5K Sell
1,121
-685
-38% -$3.93K ﹤0.01% 2527
2025
Q4 		$9.84K Sell
1,806
-279
-13% -$1.66K ﹤0.01% 2610
2025
Q3 		$12.9K Buy
2,085
+1,371
+192% +$8.97K ﹤0.01% 2355
2025
Q2 		$4.47K Sell
714
-86
-11% -$503 ﹤0.01% 2572
2025
Q1 		$4.69K Sell
800
-686
-46% -$5.19K ﹤0.01% 2194
2024
Q4 		$12.2K Buy
1,486
+1,323
+812% +$12.5K ﹤0.01% 2075
2024
Q3 		$1.45K Buy
+163
New +$1.4K ﹤0.01% 2353

Other funds holding AURA

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Sterling Capital Management's AURA Position: Q2 2026 in Review

Sterling Capital Management reduced its Aura Biosciences (AURA) stake by 82% in Q2 2026, selling an estimated $6.55K and leaving 205 shares worth $1.46K. The position accounts for ﹤0.01% of the portfolio, ranked #3061.

Sterling Capital Management first reported a position in AURA in Q3 2024 and has held it in 8 quarters since. The position peaked at $12.9K in Q3 2025. 147 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

  • Sterling Capital Management held 205 shares of Aura Biosciences worth $1.46K as of Q2 2026.
  • Sterling Capital Management sold 916 Aura Biosciences shares in Q2 2026, an estimated $6.55K.
  • Aura Biosciences made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #3061 holding.
  • Sterling Capital Management first reported a position in Aura Biosciences in Q3 2024 and has held it in 8 quarters since.
  • Sterling Capital Management's Aura Biosciences position peaked at $12.9K in Q3 2025.
  • 147 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.